Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); Solid ASCRS Meeting
Tweet
Share
E-mailGet Alerts STAA Hot Sheet
Price: $23.14 +0.30%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on STAAR Surgical (NASDAQ: STAA) price target of $14.50.
Analyst, Jason R. Mills, said, "We believe STAAR had a solid ASCRS meeting last week, with a large booth, robust traffic, and the most presentations the company has ever had at the meeting. The ICL was highlighted in several podium presentations, and STAA had a strong slate of in-booth presentations. In sum, these were important stepping stones ahead of FDA approval of the Toric ICL."
"We project STAAR Surgical will be one of just a few companies that deliver 15%+ top-line growth in med-tech over the next few years. We estimate there are fewer than a dozen companies with this kind of revenue growth profile over the next two years."
For an analyst ratings summary and ratings history on STAAR Surgical click here. For more ratings news on STAAR Surgical click here.
Shares of STAAR Surgical closed at $11.18 yesterday.
Analyst, Jason R. Mills, said, "We believe STAAR had a solid ASCRS meeting last week, with a large booth, robust traffic, and the most presentations the company has ever had at the meeting. The ICL was highlighted in several podium presentations, and STAA had a strong slate of in-booth presentations. In sum, these were important stepping stones ahead of FDA approval of the Toric ICL."
"We project STAAR Surgical will be one of just a few companies that deliver 15%+ top-line growth in med-tech over the next few years. We estimate there are fewer than a dozen companies with this kind of revenue growth profile over the next two years."
For an analyst ratings summary and ratings history on STAAR Surgical click here. For more ratings news on STAAR Surgical click here.
Shares of STAAR Surgical closed at $11.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
